-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Taysha Gene Therapies, Inc. quarterly and annual Revenues in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
- Taysha Gene Therapies, Inc. Revenues for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
- Taysha Gene Therapies, Inc. Revenues for the twelve months ending 30 Sep 2025 was $6,310,000, a 36% decline year-over-year.
- Taysha Gene Therapies, Inc. annual Revenues for 2024 was $8,333,000, a 46% decline from 2023.
- Taysha Gene Therapies, Inc. annual Revenues for 2023 was $15,451,000, a 518% increase from 2022.